At the Envision Summit 2025 in San Juan, Puerto Rico, Sharon Fekrat, MD, FACS, FASRS talked about multi-modal retinal and ...
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...
When even the most highly trained surgeons perform procedures on the retina—one of the smallest, most delicate parts of the ...
The RetinalGeniXâ„¢ imaging system is designed to allow routine screenings to be conducted by general practitioners, optometric ...
RetinalGenix Technologies Inc OTCQB:RTGN ("RetinalGenix" or the "Company"), announced today that it has achieved an important milestone in developing ...
A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic deficiency. Scientists at UCL and Moorfields Eye Hospital successfully injected ...
Regular self-care is crucial for maintaining eye health and preventing issues like soreness and burning. Adequate intake of ...
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
19h
Live Science on MSNNorrie disease: The rare genetic disorder that makes people go blind and deafNorrie disease is an extremely rare, inherited genetic disorder that causes vision loss and was first described in Denmark in ...
Sukumar Murali's research underscores the potential of this technology in revolutionizing eye care. As these innovations ...
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results